The Need for Large-Scale Randomized Evidence Without Undue Emphasis on Small Trials, Meta-analyses, or Subgroup Analyses

被引：110

作者：

Hennekens, Charles H. ^{[1
,2
]}

DeMets, David ^{[3
]}

机构：

[1] Florida Atlantic Univ, Dept Clin Sci & Med Educ, Charles E Schmidt Coll Biomed Sci, Boca Raton, FL 33431 USA

[2] Florida Atlantic Univ, Ctr Excellence, Boca Raton, FL 33431 USA

[3] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI 53706 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2009年 / 302卷 / 21期

关键词：

ACUTE MYOCARDIAL-INFARCTION; INTRAVENOUS MAGNESIUM; ATRIAL-FIBRILLATION; PREVENTION;

D O I：

10.1001/jama.2009.1756

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2361 / 2362

页数：2

共 10 条

[1]

COLLINS R, 1995, LANCET, V345, P669

[2]

Disertori M, 2009, NEW ENGL J MED, V360, P1606, DOI 10.1056/NEJMoa0805710

[3] Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers - A meta-analysis [J].

Healey, JS ;

Baranchuk, A ;

Crystal, E ;

Morillo, CA ;

Garfinkle, M ;

Yusuf, S ;

Connolly, SJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (11) :1832-1839

[4]

Hennekens C.H., 1987, EPIDEMIOLOGY MED

[5] Doing More Good than Harm: Need for a Cease Fire [J].

Hennekens, Charles H. ;

DeMets, David L. ;

Merz, C. Noel Bairey ;

Borzak, Steven L. ;

Borer, Jeffrey S. .

AMERICAN JOURNAL OF MEDICINE, 2009, 122 (04) :315-316

[6] Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial [J].

Home, Philip D. ;

Pocock, Stuart J. ;

Beck-Nielsen, Henning ;

Curtis, Paula S. ;

Gomis, Ramon ;

Hanefeld, Markolf ;

Jones, Nigel P. ;

Komajda, Michel ;

McMurray, John J. V. .

LANCET, 2009, 373 (9681) :2125-2135

[7] Discrepancies between meta-analyses and subsequent large randomized, controlled trials [J].

LeLorier, J ;

Gregoire, G ;

Benhaddad, A ;

Lapierre, J ;

Derderian, F .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (08) :536-542

[8] Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes (vol 356, pg 2457, 2007) [J].

Nissen, Steven E. ;

Wolski, Kathy .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24) :2457-2471

[9] EFFECTS OF INTRAVENOUS MAGNESIUM IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - OVERVIEW OF RANDOMIZED TRIALS [J].

TEO, KK ;

YUSUF, S ;

COLLINS, R ;

HELD, PH ;

PETO, R .

BMJ-BRITISH MEDICAL JOURNAL, 1991, 303 (6816) :1499-1503

[10]

US Food and Drug Administration, 2008, Guidance for industry. Diabetes mellitus-evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes

← 1 →